Evidence map›Paper›PMID 26528713›Full record

ArticlePloS one2015

The Role of CHI3L1 (Chitinase-3-Like-1) in the Pathogenesis of Infections in Burns in a Mouse Model.

Stefan Bohr, Suraj J Patel, Radovan Vasko, Keyue Shen, Alexander Golberg, Francois Berthiaume, Martin L Yarmush

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Raoultella planticola bacteremia-induced fatal septic shock following burn injury.Annals of clinical microbiology and antimicrobials · 2018
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 3 countries.

Stefan BohrCenter for Engineering in Medicine, Shriners Hospitals for Children and Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States of America; Department Plastic and Hand Surgery-Burn Center, UKA University Clinics RWTH, Aachen, Germany.
Suraj J PatelCenter for Engineering in Medicine, Shriners Hospitals for Children and Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States of America.
Radovan VaskoDepartment of Medicine, New York Medical College, Valhalla, NY, United States of America; Department of Nephrology & Rheumatology, UMG University Clinics, Goettingen, Germany.
Keyue ShenCenter for Engineering in Medicine, Shriners Hospitals for Children and Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States of America.
Alexander GolbergCenter for Engineering in Medicine, Shriners Hospitals for Children and Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States of America; Porter School of Environmental Studies, Tel Aviv University, Tel Aviv, Israel.
Francois BerthiaumeDepartment of Biomedical Engineering, Rutgers University, New Brunswick, NJ, United States of America.
Martin L YarmushCenter for Engineering in Medicine, Shriners Hospitals for Children and Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States of America; Department of Biomedical Engineering, Rutgers University, New Brunswick, NJ, United States of America.
Shriners Hospitals for Children - Erie · USMassachusetts General Hospital · USNew York Medical College · USRutgers, The State University of New Jersey · USRWTH Aachen University · DETel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In severe burn injury the unique setting of a depleted, dysfunctional immune system along with a loss of barrier function commonly results in opportunistic infections that eventually proof fatal. Unfortunately, the dynamic sequence of bacterial contamination, colonization and eventually septic invasion with bacteria such as Pseudomonas species is still poorly understood although a limiting factor in clinical decision making. Increasing evidence supports the notion that inhibition of bacterial translocation into the wound site may be an effective alternative to prevent infection. In this context we investigated the role of the mammalian Chitinase-3-Like-1 (CHI3L1) non-enyzmatic protein predominately expressed on epithelial as well as innate immune cells as a potential bacterial-translocation-mediating factor. We show a strong trend that a modulation of chitinase expression is likely to be effective in reducing mortality rates in a mouse model of burn injury with superinfection with the opportunistic PA14 Pseudomonas strain, thus demonstrating possible clinical leverage.

Indexed as

AnimalsBurnsChitinase-3-Like Protein 1Disease Models, AnimalGlycoproteinsMiceMice, Inbred C57BLPseudomonas aeruginosaSepsisSystemic Inflammatory Response SyndromeChil1 protein, mouseChitinase-3-Like Protein 1Glycoproteins

Identifiers

PMID26528713
PMCPMC4631332
OpenAlexW2177956265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.